Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPERIN: Aspirin Dosing for Preeclampsia Prevention
NCT03893630Phase 2Completed
- Start
- Apr 2019
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of aspirin in preeclampsia (3 arms). Primary endpoint: Change in Pulsatility Index (PI). Started Apr 2019; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT03893630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03893630.